Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
bluebird's (BLUE) Gene Therapy Gets FDA Nod for Beta-Thalassemia
12:03pm, Thursday, 18'th Aug 2022
bluebird's (BLUE) Zynteglo gets FDA-approval for transfusion-dependent beta-thalassemia in adult and pediatric patients. The stock gains.
Bluebird announces FDA approval of gene therapy for rare blood disease
02:59pm, Wednesday, 17'th Aug 2022
Shares of Buebird Bio Inc. BLUE, +7.90% jumped 12.1% in trading on Wednesday after the Food and Drug Administration approved the company's gene therapy as a treatment for beta‑thalassemia in some ad
bluebird bio (BLUE) Focused on Pipeline Amid Marketed Drug Dearth
10:32am, Monday, 15'th Aug 2022
bluebird bio's (BLUE) efforts to develop its gene-therapy pipeline are impressive. The FDA is reviewing BLUE's filing for beti-cel as a treatment for beta thalassemia and eli-cel for cerebral adrenole
2 Tips for Investing in Biotech Stocks With High Growth Potential
09:53am, Sunday, 14'th Aug 2022
Investing in biotech stocks without any drugs on the market can be scary. These suggestions can help you make money in this high-risk sector.
5 Sizzling Well-Known Stocks Rated Buy Trading Under $10 With Big Upside Potential
06:15am, Saturday, 13'th Aug 2022
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
bluebird (BLUE) Q2 Loss Narrower Than Expected, Sales Miss
12:47pm, Friday, 05'th Aug 2022
bluebird (BLUE) posts a narrower-than-expected loss in the second quarter. However, sales miss estimates.
Bluebird Bio (BLUE) Reports Q2 Loss, Lags Revenue Estimates
09:03pm, Thursday, 04'th Aug 2022
Bluebird (BLUE) delivered earnings and revenue surprises of 1.53% and 76.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
10:01am, Friday, 08'th Jul 2022
These high-tech biotech stocks made a sharp U-turn this week after a rough start to the year.
7 Oversold Stocks to Buy in July 2022
06:47pm, Wednesday, 06'th Jul 2022
Investors are on the hunt for oversold stocks with bargain valuations that could jump in value once optimism returns to the stock market. The post 7 Oversold Stocks to Buy in July 2022 appeared first
Bluebird (BLUE) Surges 18%: Is This an Indication of Further Gains?
10:08am, Wednesday, 06'th Jul 2022
Bluebird (BLUE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Bluebird Bio Stock Is Flying Today
01:29pm, Tuesday, 05'th Jul 2022
There's probably a short squeeze in progress.
2 Biotech Stocks That Could Soar in the Third Quarter
05:41am, Saturday, 02'nd Jul 2022
Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.
Is Now a Good Time to Buy This Biotech Stock?
03:30pm, Thursday, 23'rd Jun 2022 The Motley Fool
The company may be about to turn things around.
Is Now a Good Time to Buy This Biotech Stock?
11:30am, Thursday, 23'rd Jun 2022
The company may be about to turn things around.
Best Penny Stocks To Buy? 4 To Watch Right Now
05:46pm, Wednesday, 22'nd Jun 2022 PennyStocks
Penny stocks to buy? 4 to watch this week.
The post Best Penny Stocks To Buy? 4 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
